Stablepoint Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2011237 BRAINTREE, MA

Position in LLY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$3,886,153

+$857,351 QoQ

Shares Held

3,240

-1.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#1,914

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stablepoint Partners, LLC holds $55,827,894 across 12 Drug Manufacturers - General names. LLY ranks #7 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,144	$11,277,865
2	MRK	Merck & Co., Inc.	67,206	$8,635,971
3	JNJ	Johnson & Johnson	29,950	$7,606,401
4	GSK	GSK plc	109,711	$5,751,050
5	ABBV	AbbVie Inc.	21,670	$5,453,038
6	PFE	Pfizer Inc	201,036	$4,840,946
7	LLY	ELI LILLY & Co This page	3,240	$3,886,153
8	GILD	Gilead Sciences, Inc.	23,047	$2,911,757

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,886,153	3,240	-1.6%	Shares	Sole	2026-07-09
2026-03-31	$3,028,802	3,293	-0.8%	Shares	Sole	2026-04-30
2025-12-31	$3,567,937	3,320	-1.4%	Shares	Sole	2026-01-13
2025-09-30	$2,569,021	3,367	+2.8%	Shares	Sole	2025-11-03
2025-06-30	$2,553,740	3,276	-2.4%	Shares	Sole	2025-08-13
2025-03-31	$2,770,928	3,355	+4.5%	Shares	Sole	2025-04-11
2024-12-31	$2,479,664	3,212	-3.8%	Shares	Sole	2025-01-21
2024-09-30	$2,958,153	3,339	-4.2%	Shares	Sole	2024-10-11
2024-06-30	$3,156,154	3,486	-1.4%	Shares	Sole	2024-08-02
2024-03-31	$2,751,644	3,537	+28.2%	Shares	Sole	2024-04-23
2023-12-31	$1,607,693	2,758	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.